YOUDIM; Moussa B. H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for YOUDIM; Moussa B. H..The latest application filed is for "methods for prognosis or treatment of parkinson's disease".

Company Profile

0.21.27

YOUDIM; Moussa B. H. - Nesher IL
Youdim; Moussa B. H. - Guangzhou CN
Youdim; Moussa B. H. - Haifa N/A IL
Youdim; Moussa B. H. - Tivon IL
Youdim, Moussa B.H. - Remez Tivon IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods For Prognosis Or Treatment Of Parkinson's Disease App 20200354791 - YARDEN; Jennifer ; et al.	2020-11-12
Compounds with neural protective effect, and preparation and use thereof Grant 9,938,235 - Wang , et al. April 10, 2	2018-04-10
Methods, Compositions And Devices For Treatment Of Motor And Depression Symptoms Associated With Parkinson's Disease App 20170151192 - YOUDIM; Moussa B.H. ; et al.	2017-06-01
Compounds With Neural Protective Effect, And Preparation And Use Thereof App 20160326099 - WANG; Yuqiang ; et al.	2016-11-10
Methods, Compositions And Devices For Treatment Of Motor And Depression Symptoms Associated With Parkinson's Disease App 20160022572 - YOUDIM; Moussa B.H. ; et al.	2016-01-28
Neuroprotective and neuro-restorative iron chelators and monoamine oxidase inhibitors and uses thereof Grant 9,034,303 - Zurawski, Jr. , et al. May 19, 2	2015-05-19
Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them Grant 8,802,675 - Youdim , et al. August 12, 2	2014-08-12
Neuroprotective And Neuro-restorative Iron Chelators And Monoamine Oxidase Inhibitors And Uses Thereof App 20140186280 - ZURAWSKI, JR.; Vincent R. ; et al.	2014-07-03
Neuroprotective iron chelators and pharmaceutical compositions comprising them Grant 8,685,955 - Youdim , et al. April 1, 2	2014-04-01
Corroles For Neuroprotection And Neurorescue App 20140045809 - YOUDIM; Moussa B.H. ; et al.	2014-02-13
Neuroprotective And Neuro-restorative Iron Chelators And Monoamine Oxidase Inhibitors And Uses Thereof App 20130330284 - Zurawski; Vincent R. ; et al.	2013-12-12
Peripheral Blood Gene Markers For Early Diagnosis Of Parkinson's Disease App 20130217028 - Mandel; Silva A. ; et al.	2013-08-22
Methods for treatment of renal failure Grant 8,263,655 - Binah , et al. September 11, 2	2012-09-11
Methods For Treatment Of Cardiovascular Disorders And Diseases App 20120095107 - YOUDIM; Moussa B.H. ; et al.	2012-04-19
Neuroprotective Multifunctional Compounds And Pharmaceutical Compositions Comprising Them App 20120040993 - Youdim; Moussa B. H. ; et al.	2012-02-16
Methods for treatment of cardiovascular disorders and diseases Grant 8,097,608 - Youdim , et al. January 17, 2	2012-01-17
Diagnostic Test For Parkinson's Disease App 20100221735 - YOUDIM; Moussa B.H. ; et al.	2010-09-02
Methods For Evaluation Prognosis And Follow-up Of Drug Treatment Of Psychiatric Diseases Or Disorders App 20090269770 - Silver; Henry ; et al.	2009-10-29
Method for identifying antipsychotic drug candidates App 20090208979 - SILVER; Henry ; et al.	2009-08-20
Method For Preventing Or Attenuating Anthracycline-induced Cardiotoxicity App 20080090915 - Youdim; Moussa B.H. ; et al.	2008-04-17
Diagnostic Test For Parkinson's Disease App 20070281299 - Youdim; Moussa B.H. ; et al.	2007-12-06
Aminoindan derivatives Grant RE39,616 - Chorev , et al. May 8, 2	2007-05-08
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof App 20070100001 - Youdim; Moussa B.H. ; et al.	2007-05-03
Methods for treatment of renal failure App 20070082958 - Binah; Ofer ; et al.	2007-04-12
Methods for treatment of cardiovascular disorders and diseases App 20060287401 - Youdim; Moussa B.H. ; et al.	2006-12-21
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof App 20060094783 - Youdim; Moussa B.H. ; et al.	2006-05-04
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof Grant 6,956,060 - Youdim , et al. October 18, 2	2005-10-18
Use of propargylamine as neuroprotective agent App 20050191348 - Youdim, Moussa B.H. ; et al.	2005-09-01
Compositions and methods for treatment of cardiovascular disorders and diseases App 20050171210 - Youdim, Moussa B.H. ; et al.	2005-08-04
Pharmaceutical compositions comprising iron chelators for the treatment of neurodegenerative disorders and some novel iron chelators Grant 6,855,711 - Warshawsky , et al. February 15, 2	2005-02-15
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof App 20030212145 - Youdim, Moussa B.H. ; et al.	2003-11-13
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof Grant 6,630,514 - Youdim , et al. October 7, 2	2003-10-07
Use of r-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof App 20030065038 - Youdim, Moussa B.H. ; et al.	2003-04-03
Aminoindan derivatives App 20020188020 - Chorev, Michael ; et al.	2002-12-12
Compositions Containing And Methods Of Using 1-aminoindan And Derivatives Thereof And Process For Preparing Optically Active 1-aminoindan Derivatives App 20020068839 - COHEN, SASSON ; et al.	2002-06-06
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives Grant 5,994,408 - Cohen , et al. November 30, 1	1999-11-30
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives Grant 5,914,349 - Cohen , et al. June 22, 1	1999-06-22
R-enantiomer of N-propargyl-1-aminoindan for the treatment of dementia Grant 5,891,923 - Youdim , et al. April 6, 1	1999-04-06
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives Grant 5,880,159 - Herzig , et al. March 9, 1	1999-03-09
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives Grant 5,877,221 - Cohen , et al. March 2, 1	1999-03-02
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof Grant 5,744,500 - Youdim , et al. April 28, 1	1998-04-28
R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereof Grant 5,519,061 - Youdim , et al. May 21, 1	1996-05-21
R-enantiomers of N-propargyl-aminoindan compounds, their preparation and pharmaceutical compositions containing them Grant 5,457,133 - Youdim , et al. October 10, 1	1995-10-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.